Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 2
2017 2
2018 8
2019 5
2020 2
2021 1
2022 2
2023 2
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls.
Holzgreve A, Nitschmann A, Maier SH, Büttner M, Schönecker S, Marschner SN, Fleischmann DF, Corradini S, Belka C, la Fougère C, Bodensohn R, Albert NL, Niyazi M. Holzgreve A, et al. Among authors: schonecker s. Radiother Oncol. 2024 Sep;198:110386. doi: 10.1016/j.radonc.2024.110386. Epub 2024 Jun 14. Radiother Oncol. 2024. PMID: 38880414 Free article. Review.
Adjuvant Therapy for Elderly Breast Cancer Patients after Breast-Conserving Surgery: Outcomes in Real World Practice.
Rogowski P, Schönecker S, Konnerth D, Schäfer A, Pazos M, Gaasch A, Niyazi M, Boelke E, Matuschek C, Haussmann J, Braun M, Pölcher M, Würstlein R, Harbeck N, Belka C, Corradini S. Rogowski P, et al. Among authors: schonecker s. Cancers (Basel). 2023 Apr 17;15(8):2334. doi: 10.3390/cancers15082334. Cancers (Basel). 2023. PMID: 37190263 Free PMC article.
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).
Maier SH, Schönecker S, Anagnostatou V, Garny S, Nitschmann A, Fleischmann DF, Büttner M, Kaul D, Imhoff D, Fokas E, Seidel C, Hau P, Kölbl O, Popp I, Grosu AL, Haussmann J, Budach W, Celik E, Kahl KH, Hoffmann E, Tabatabai G, Paulsen F, Holzgreve A, Albert NL, Mansmann U, Corradini S, Belka C, Niyazi M, Bodensohn R. Maier SH, et al. Among authors: schonecker s. Clin Transl Radiat Oncol. 2024 May 4;47:100790. doi: 10.1016/j.ctro.2024.100790. eCollection 2024 Jul. Clin Transl Radiat Oncol. 2024. PMID: 38765202 Free PMC article.
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
Eze C, Guggenberger JE, Schmidt-Hegemann NS, Kenndoff S, Taugner J, Käsmann L, Schönecker S, Flörsch B, Li M, Belka C, Manapov F. Eze C, et al. Among authors: schonecker s. Cancer. 2022 Jun 15;128(12):2358-2366. doi: 10.1002/cncr.34201. Epub 2022 Apr 13. Cancer. 2022. PMID: 35417563 Free article.
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12).
Bodensohn R, Fleischmann DF, Maier SH, Anagnostatou V, Garny S, Nitschmann A, Büttner M, Mücke J, Schönecker S, Unger K, Hoffmann E, Paulsen F, Thorwarth D, Holzgreve A, Albert NL, Corradini S, Tabatabai G, Belka C, Niyazi M. Bodensohn R, et al. Among authors: schonecker s. Clin Transl Radiat Oncol. 2023 Dec 3;45:100706. doi: 10.1016/j.ctro.2023.100706. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38116137 Free PMC article.
Thermal surface free energy and stress of iron.
Schönecker S, Li X, Johansson B, Kwon SK, Vitos L. Schönecker S, et al. Sci Rep. 2015 Oct 6;5:14860. doi: 10.1038/srep14860. Sci Rep. 2015. PMID: 26439916 Free PMC article.
MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience.
Hadi I, Eze C, Schönecker S, von Bestenbostel R, Rogowski P, Nierer L, Bodensohn R, Reiner M, Landry G, Belka C, Niyazi M, Corradini S. Hadi I, et al. Among authors: schonecker s. Radiat Oncol. 2022 Jan 15;17(1):8. doi: 10.1186/s13014-022-01981-z. Radiat Oncol. 2022. PMID: 35033132 Free PMC article.
29 results